Age-Related Macular Degeneration (AMD) affects 20 million Americans. 70% of the cause of AMD is due to genetics. Visible Genomics’ AMD genetic testing can help you better understand your risk of macular degeneration and plan effective treatment.
AMDiGuard DNA Risk Test
The AMDiGuard Risk Test is designed to use DNA through a simple swab combined with patients’ basic health factors and provide a risk level of aged-related macular degeneration based on our scientific analysis of both factors.
AMDiGuard DNA Progression Test
The AMDiGuard Progression Test is designed to learn more about the risk of advanced AMD for patients who have early to intermediate AMD.
Macular Degeneration is a progressive and degenerative disease affecting the central part of the retina, the macula. It is the leading cause of irreversible vision loss in the United States. Its prevalence is increasing with the growth of our aging population. In the U.S., over 11 million people suffer from AMD (1.75 million individuals have advanced forms of AMD). One question consistently asked is if Macular Degeneration is hereditary? 70% of the cause of AMD is due to genetics. To learn more and see how we can help, click here.
The Time Is Now. Incorporating a hereditary AMD genetic testing that provides comprehensive risk assessment to provide advanced awareness of disease risk will:
Empower the patient and physician to make informed clinical and lifestyle decisions together
Help slow or prevent disease
Provide greater access to more patients through affordable, easy, and understandable genetic risk testing
Deliver personalized preventative medicine
To learn more on how to begin utilizing the AMDiGuard genetic macular degeneration tests, click here.
We have a healthy dissatisfaction with the status quo and the current pace of change in the industry. So we’ve combined our decades of experience in AMD Genetic Testing with the highest ethical standards to develop macular degeneration genetic testing capabilities that open a window of knowledge into your eye health. To learn about our hereditary AMD genetic tests, our company, and our team, click here.
Amanda Frye, O.D., Stirling Eyecare, Butler, PA
“Visible Genomics has been a great addition to our practice. It allows us to customize our treatment and monitoring plan for each of our patients, with current macular degeneration, as well as those who have family history, and risk factors for the disease. Ordering the genetic testing is easy, efficient, and the results are easy to interpret and discuss with our patients. Mike has been very helpful integrating the testing within our office and is always ready to help if we run into any issues. There is no lack of communication when it comes to streamlining the testing process, and we are very happy with the results. Thank you Visible Genomics!”
Dan C. Thieme, O.D., Meridian Family Eyecare, Meridian, ID
“We have used genetic testing in our office since 2018. Visible Genomics is a step forward which looks at not only genetic factors, but other essential elements that contribute to our patients' probability of developing this debilitating eye disease. Taken together, this insight contributes greatly to our comprehensive eye care for macular degeneration. We now provide targeted, personalized care and more frequent follow-up visits to at-risk patients to prevent vision loss.”
“I recently had a DNA test with Visible Genomics, on the recommendation from my eye doctor. Both of my parents suffered from Macular Degeneration Wet. After the results came in he spent time on the phone and reviewed all of the results, which showed I was at a moderate to high risk for macular degeneration. I would highly suggest this test for somebody that has a family history such as mine.” — Actual Patient
Claudio Lagunas, Administrator & Medical Director at Vision Source North Houston, TX
It’s Medical Monday and we’re proud to announce the addition of Genetic Testing for Age-Related Macular Degeneration. Now Available at Lifetime Eyecare Associates. Are you at Risk?
#AMDExperts #VisibleGenomics #preventblindness #VisionSource
Dr. Steven Miller, OD, Miller Vision Specialties, Greensboro, NC
Visible Genomics provides a streamlined service to elevate our level of patient care. We're glad to be partnered with them, and we feel great about being able to help our patients by optimizing treatment modalities for macular degeneration.
HEA is endorsed by more state optometric associations than any other network.
